XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Sep. 30, 2016
Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (2,370,132) $ (2,524,331)
Adjustments to reconcile net loss to net cash used in operating activities:    
Provision for doubtful accounts, net of recoveries 69,633 0
Loss on disposal of property and equipment 6,185 0
Depreciation and amortization expense 335,213 141,435
Deferred income tax 0 6,129
Stock-based compensation expense 493,758 152,733
Amortization of deferred financing costs 37,926 46,745
Amortization of debt discount 0 (47,875)
Change in fair value of warrant and conversion feature liabilities (1,333,333) 116,866
Changes in assets and liabilities:    
Accounts receivable (1,254,806) (214,131)
Other receivables 290,272 (80,776)
Due from affiliates 453 16,345
Prepaid expenses and other current assets (136,450) (131,091)
Deferred financing costs 0 513,646
Other assets (5,537) 6,570
Accounts payable and accrued liabilities (27,596) 1,592,267
Deferred rent liability 90,498 0
Medical liabilities (601,317) 76,638
Net cash used in operating activities (4,405,233) (328,830)
Cash flows from investing activities:    
Property and equipment acquired (205,775) (42,572)
Net cash used in investing activities (205,775) (42,572)
Cash flows from financing activities:    
Proceeds from Lines of Credit 75,000 0
Principal payments on note payable 0 (122,500)
Distributions to non-controlling interest shareholder (1,050,000) (595,418)
Proceeds from the exercise of warrants 172,000 0
Principal payments on lines of credit (62,500) 0
Net cash used in financing activities (865,500) (717,918)
Net decrease in cash and cash equivalents (5,476,508) (1,089,320)
Cash and cash equivalents, beginning of period 9,270,010 5,014,242
Cash and cash equivalents, end of period 3,793,502 3,924,922
Supplementary disclosures of cash flow information:    
Interest paid 10,199 380,748
Income taxes paid $ 16,400 $ 32,197